Research Article

Astragalus Polysaccharide Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the PI3k/Akt and p38MAPK Pathways

Figure 1

Increased levels of serum myocardial enzymes accompanied by heart dysfunction in cancer patients treated with doxorubicin. The average left ventricle ejection fraction (LVEF %) (a), median serum cTNT (b), and CK-MB (c) levels before and after chemotherapy (, , ).
(a)
(b)
(c)